NewLimit
NewLimit is a startup headquartered in South San Francisco, United States, founded in 2021. It has raised at least $129.8m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
NewLimit has raised at least $129.8m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
NewLimit sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.
Other startups in South San Francisco
- Addition Therapeutics
- Asher Biotherapeutics
- Burnbot
- Dualitas Therapeutics
- Firefly Bio
- Kamau Therapeutics
- Long Bridge Medical
- Lycia Therapeutics
- Mahzi Therapeutics
- Moonwalk Biosciences
- NGM Bio Holdings
Related
- Innovation profile of South San Francisco
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does NewLimit do?
NewLimit is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has NewLimit raised?
At least $129.8m, according to its Form D filings with the US Securities and Exchange Commission.
Where is NewLimit based?
NewLimit is headquartered in South San Francisco, United States.
When was NewLimit founded?
NewLimit was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.